Which medications in the drug class P-Selectin Inhibitor are used in the treatment of Sickle Cell Anemia?

Updated: May 12, 2021
  • Author: Joseph E Maakaron, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

P-Selectin Inhibitor

Binding P-selectin on the surface of the activated endothelium and platelet cells blocks interactions between endothelial cells, platelets, red blood cells, and leukocytes; thereby, decreasing vaso-occlusive crises.

Crizanlizumab (Adakveo, crizanlizumab-tmca)

P-selectin inhibitor indicated to reduce frequency of vasoocclusive crises in adults with sickle cell disease.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!